TEK and neoplasm: Anti-Ang2 monoclonal antibodies and peptide-Fc fusion proteins that selectively neutralize the interaction between Ang2 or both Ang1 and Ang2 with Tie2 have demonstrated inhibition of tumour growth and angiogenesis in human tumour xenografts and orthotopic mouse tumours.